Equity Incentive Plan Sample Contracts

Medifirst Solutions, Inc. – Medifirst Solutions, Inc. 2019 EQUITY INCENTIVE PLAN (January 11th, 2019)

This Medifirst Solutions, Inc. 2019 EQUITY Incentive Plan (the "Plan") is designed to retain directors, executives and selected employees and consultants and reward them for making contributions to the success of the Company. These objectives are accomplished by making long-term incentive awards under the Plan thereby providing Participants with a proprietary interest in the growth and performance of the Company.

Cirius Therapeutics, Inc. – Cirius Therapeutics, Inc. 2019 Equity Incentive Plan Adopted by the Board of Directors: Approved by the Stockholders: Ipo Date: (January 11th, 2019)
Cirius Therapeutics, Inc. – CIRIUS THERAPEUTICS, INC. 2017 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS: March 24, 2017 APPROVED BY THE STOCKHOLDERS: March 24, 2017 AMENDED BY THE BOARD OF DIRECTORS: August 22, 2018 APPROVED BY THE STOCKHOLDERS: August 22, 2018 AMENDED BY THE BOARD OF DIRECTORS: October 26, 2018 APPROVED BY THE STOCKHOLDERS: November 23, 2018 TERMINATION DATE: March 24, 2027 (January 11th, 2019)
Beyond Meat, Inc. – 2018 Equity Incentive Plan (January 9th, 2019)
Beyond Meat, Inc. – Beyond Meat, Inc. 2011 Equity Incentive Plan (January 9th, 2019)
Guardion Health Sciences, Inc. – Guardion Health Sciences, Inc. 2018 Equity Incentive Plan (January 7th, 2019)
Alector, Inc. – Alector, Inc. (The Company) Believes That Providing Cash and Equity Compensation to Members of Its Board of Directors (The Board, and Members of the Board, the Directors) Represents an Effective Tool to Attract, Retain and Reward Directors Who Are Not Employees of the Company (The Outside Directors). This Outside Director Compensation Policy (The Policy) Formalizes the Companys Policy Regarding Cash Compensation and Grants of Equity Awards to Its Outside Directors. Unless Otherwise Defined Herein, Capitalized Terms Used in This Policy Will Have the Meaning Given Such Term in the Companys 2019 (January 7th, 2019)
Alector, Inc. – Alector, Inc. 2019 Equity Incentive Plan (January 7th, 2019)
Cubesmart 2007 Equity Incentive Plan (As Amended and Restated, Effective June 1, 2016) (January 3rd, 2019)

CubeSmart, a Maryland real estate investment trust (the "Company"), grants common shares of beneficial interest, $.01 par value (the "Shares"), of the Company to the individual named below, subject to the vesting conditions set forth in the attachment. The grant of Shares is made in consideration of the services to be rendered by Grantee to the Company. Additional terms and conditions of the grant are set forth in this cover sheet, in the attachment, and in the Company's 2007 Equity Incentive Plan, as amended from time to time (the "Plan").

Macdonald Dettwiler & Associates Ltd – AMENDMENT TO THE MAXAR TECHNOLOGIES LTD. OMNIBUS EQUITY INCENTIVE PLAN January 1, 2019 (January 2nd, 2019)

This Amendment (this "Amendment") to the Maxar Technologies Ltd. Omnibus Equity Incentive Plan (the "Plan") is effective as of the date first set forth above, it being approved by the Board of Directors of Maxar Technologies Inc., a Delaware corporation (the "Company"), and Maxar Technologies Ltd., a corporation organized under the laws of British Columbia, Canada, pursuant to Section 13 of the Plan. The Plan is hereby amended as follows:

Macdonald Dettwiler & Associates Ltd – AMENDMENT TO THE MAXAR TECHNOLOGIES LTD. OMNIBUS EQUITY INCENTIVE PLAN January 1, 2019 (January 2nd, 2019)

This Amendment (this "Amendment") to the Maxar Technologies Ltd. Omnibus Equity Incentive Plan (the "Plan") is effective as of the date first set forth above, it being approved by the Board of Directors of Maxar Technologies Inc., a Delaware corporation (the "Company"), and Maxar Technologies Ltd., a corporation organized under the laws of British Columbia, Canada, pursuant to Section 13 of the Plan. The Plan is hereby amended as follows:

Macdonald Dettwiler & Associates Ltd – AMENDMENT TO THE MAXAR TECHNOLOGIES LTD. OMNIBUS EQUITY INCENTIVE PLAN January 1, 2019 (January 2nd, 2019)

This Amendment (this "Amendment") to the Maxar Technologies Ltd. Omnibus Equity Incentive Plan (the "Plan") is effective as of the date first set forth above, it being approved by the Board of Directors of Maxar Technologies Inc., a Delaware corporation (the "Company"), and Maxar Technologies Ltd., a corporation organized under the laws of British Columbia, Canada, pursuant to Section 13 of the Plan. The Plan is hereby amended as follows:

InfoSonics – Cool Holdings, Inc. Amended and Restated 2015 Equity Incentive Plan (January 2nd, 2019)

The purpose of the Cool Holdings, Inc. Amended and Restated 2015 Equity Incentive Plan is to attract, retain and motivate employees, officers, directors, consultants, agents, advisors and independent contractors of the Company and its Related Companies by providing them with the opportunity to acquire a proprietary interest in the Company and to align their interests and efforts with the long-term interests of the Company's stockholders.

Itamar Medical Ltd. – Itamar Medical Ltd. 2007 Equity Incentive Plan (December 31st, 2018)
Itamar Medical Ltd. – ISRAELI EQUITY INCENTIVE PLAN 2016 as Adopted by the Board of Directors on January 21, 2016 (December 31st, 2018)
Itamar Medical Ltd. – Itamar Medical Ltd. 2016 U.S. Equity Incentive Plan Adopted by the Board of Directors: January 21, 2016 Approved by the Shareholders: March 16, 2016 Termination Date: January 20, 2026 (December 31st, 2018)
Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (December 28th, 2018)

Please type or print in ink. Return all pages to Gretchen Strohminger, Head of Human Resources by close of business on December 20, 2018. Please keep a copy for your records. You may not change or revoke your elections for the period beginning January 1, 2019 and ending December 31, 2019 after December 31, 2018.

Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (December 28th, 2018)

Accelerate Diagnostics, Inc. a Delaware corporation (the "Company"), hereby establishes this 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (the "Plan") pursuant to the Accelerate Diagnostics, Inc. 2012 Omnibus Equity Incentive Plan (the "2012 Plan"). To the extent not specifically defined in this Plan, all capitalized terms used in this Plan shall have the meanings set forth in the 2012 Plan.

First Amendment to the Diamondrock Hospitality Company 2016 Equity Incentive Plan (December 26th, 2018)

This First Amendment (this Amendment) to the DiamondRock Hospitality Company 2016 Equity Incentive Plan (the Plan) is made and entered into as of December 20, 2018 (the Amendment Date) by DiamondRock Hospitality Company, a Maryland corporation (the Company). All capitalized terms used but not defined in this Amendment shall have the meanings ascribed to such terms in the Plan.

AMENDMENT #1 TO THE AMENDED AND RESTATED AMICUS THERAPEUTICS, INC. 2007 EQUITY INCENTIVE PLAN WHEREAS, the Board of Directors (The "Board") of Amicus Therapeutics, Inc. (The "Company") Has Previously Approved the Amended and Restated Amicus Therapeutics, Inc. 2007 Equity Incentive Plan (The "Plan"); WHEREAS, Pursuant to Section 13 of the Plan, the Board Is Empowered to Amend the Plan; And WHEREAS, the Board Determined to Make Certain Changes to the Plan as Set Forth in This Amendment #1 to the Plan (The "Amendment"). NOW THEREFORE, the Plan Is Amended as Follows Effective as of the Date Hereof (December 26th, 2018)
SolarMax Technology, Inc. – Solarmax Technology, Inc. 2016 Equity Incentive Plan (December 24th, 2018)
Gossamer Bio, Inc. – Gossamer Bio, Inc. 2017 Equity Incentive Plan (December 21st, 2018)
Dova Pharmaceuticals, Inc. – Dova Pharmaceuticals, Inc. Amended and Restated 2017 Equity Incentive Plan Adopted by the Board of Directors: June 14, 2017 Approved by the Stockholders: June 15, 2017 Amended by the Compensation Committee: December 19, 2018 Ipo Date: June 28, 2017 (December 20th, 2018)
2011 EQUITY INCENTIVE PLAN (As Amended and Restated December 18, 2018) (December 20th, 2018)
Dova Pharmaceuticals, Inc. – Dova Pharmaceuticals Restricted Stock Unit Grant Notice (Amended and Restated 2017 Equity Incentive Plan) (December 20th, 2018)

Dova Pharmaceuticals (the Company), pursuant to its Amended and Restated 2017 Equity Incentive Plan (the Plan), hereby awards to Participant a Restricted Stock Unit Award for the number of shares of the Companys Common Stock (Restricted Stock Units) set forth below (the Award). The Award is subject to all of the terms and conditions as set forth in this notice of grant (this Restricted Stock Unit Grant Notice) and in the Plan and the Restricted Stock Unit Award Agreement (the Award Agreement), both of which are attached hereto and incorporated herein in their entirety. Capitalized terms not explicitly defined herein shall have the meanings set forth in the Plan or the Award Agreement. In the event of any conflict between the terms in the Award and the Plan, the terms of the Plan shall control.

MAXLINEAR, INC. AMENDED AND RESTATED 2010 EQUITY INCENTIVE PLAN (Amended as of December 13, 2018) (December 19th, 2018)
Hypersolar Inc – Hypersolar, Inc. 2019 Equity Incentive Plan (December 19th, 2018)
THERMOGENESIS Corp. – Third Amendment to Cesca Therapeutics Inc. Amended 2016 Equity Incentive Plan (December 19th, 2018)

THIS THIRD AMENDMENT TO THE CESCA THERAPEUTICS INC. AMENDED 2016 EQUITY INCENTIVE PLAN (this "Amendment") is adopted and approved by the Board of Directors of Cesca Therapeutics, Inc., a Delaware corporation (the "Company"), as of December 14, 2018. Capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Plan (as defined below).

Natus Medical Incorporated 2018 Equity Incentive Plan Notice of Restricted Stock Unit Award (December 18th, 2018)

Unless otherwise defined herein, the terms defined in the Natus Medical Incorporated (the "Company") 2018 Equity Incentive Plan (the "Plan") will have the same meanings in this Notice of Restricted Stock Unit Award and the electronic representation of this Notice of Restricted Stock Unit Award established and maintained by the Company or a third party designated by the Company (this "Notice").

Natus Medical Incorporated 2018 Equity Incentive Plan Notice of Restricted Stock Award (December 18th, 2018)

Unless otherwise defined herein, the terms defined in the Natus Medical Incorporated 2018 Equity Incentive Plan (the "Plan") will have the same meanings in this Notice of Restricted Stock Award and any electronic representation of this Notice of Restricted Stock Award established and maintained by Natus Medical Incorporated ("Natus" or the "Company") or a third party designated by the Company (this "Notice").

Terra Tech Corp. – Stock Option Grant Under the Company's 2018 Equity Incentive Plan (December 17th, 2018)

Notwithstanding the foregoing, in the event the Participant's service is terminated by the Company or an Affiliate without Cause (as defined below) or the Participant terminates their service for Good Reason (as defined below), 100% of the Shares which would have vested in each vesting installment remaining under this Option will be vested and exercisable for purposes of Section 25(b) of the Plan unless this Option has otherwise expired or been terminated pursuant to its terms or the terms of the Plan.

Terra Tech Corp. – Stock Option Grant Under the Company's 2018 Equity Incentive Plan (December 17th, 2018)

The Company and the Participant acknowledge receipt of this Stock Option Grant Notice and agree to the terms of the Stock Option Agreement attached hereto and incorporated by reference herein, the Company's 2018 Equity Incentive Plan and the terms of this Option Grant as set forth above.

Terra Tech Corp. – Terra Tech Corp. 2018 Equity Incentive Plan (December 17th, 2018)
Terra Tech Corp. – TERRA TECH CORP. Stock Option Grant Notice Stock Option Grant Under the Company's 2018 Equity Incentive Plan (December 17th, 2018)

Vesting Schedule: This Option shall become exercisable (and the Shares issued upon exercise shall be vested) as follows provided the Participant is an Employee, director or Consultant of the Company or of an Affiliate on the applicable vesting date:

Hoth Therapeutics, Inc. – Hoth Therapeutics, Inc. 2018 Equity Incentive Plan Effective as of May 4, 2018 Hoth Therapeutics, Inc. 2018 Equity Incentive Plan Effective as of May 4, 2018 (December 14th, 2018)